Tysabri 150 mg solution for injection in pre-filled syringe
*Company:
Biogen Idec LtdStatus:
UpdatedLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Educational materials 'FOR HEALTHCARE PROFESSIONALS' (HCPs) are additional risk minimisation measures that are intended to promote the safe and effective use of the medicinal product.
(Click to Download) Physician Information and Management Guidelines for Patients with Multiple Sclerosis receiving TYSABRI therapy
Risk Minimisation Materials
(Click to Download) Treatment Initiation Form
Risk Minimisation Materials
(Click to Download) Treatment Continuation Form
Risk Minimisation Materials
(Click to Download) Treatment Discontinuation Form
Risk Minimisation Materials
(Click to Download) HCP Informational Supplement
Risk Minimisation Materials
(Click to Download) Outside Clinical Setting Administration Checklist
Risk Minimisation Materials